Presenters
Assistant Professor, Department of Medicine
Marcellus Francis L. Ramirez, MD, FPCP, FPCC, FACC
Course Details
- This webinar dedicated to pharmacists. It described the pathophysiology of hypertension and the drugs used to treat this condition. The webinar features Dr. Marcellus Ramirez as speaker.
- Duration: 26:03 min.
- CPD Points: 0.5
- Program Number: PROG-2024-75943
Telmisartan: Management of Hypertension and the Role of the Pharmacist by Dr. Marcellus Ramirez Course Outline
- How common is hypertension?
- What causes hypertension?
- The renin-angiotensin-aldosterone system
- 2018 ESC Guidelines on Hypertension
- 2020 Clinical Practice Guidelines for the Management of Hypertension in the Philippines
- Drug-related causes of poor BP Control
- Angiotensin-converting enzyme inhibitors
- Angiotensin receptor blockers
- Unique features of telmisartan
- Single-pill combination: telmisartan + amlodipine
- Hypertension Management in Complex Patients with comorbidities
- Who is the hypertensive patient at high risk?
- RAAS inhibitors for high-risk hypertensive patients
- Pathophysiology of hypertension and diabetes
- 2020 Philippines CPGs on hypertension
- Pharmaceutical Counselling
- Hypertension and CKD: Related risk factors
- Goals of hypertension treatment in chronic kidney disease
- Renal Benefits of ARBs: Telmisartan
- AMADEO
- Nephrotoxicity in CKD-HTN medications
- Dose adjustments in CKD-HTN medications